|
HSPA5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.416600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.745880E-02 |
| Normal-vs-Stage2 |
5.327600E-01 |
| Normal-vs-Stage3 |
4.194200E-01 |
| Normal-vs-Stage4 |
4.205000E-01 |
| Stage1-vs-Stage2 |
3.702000E-01 |
| Stage1-vs-Stage3 |
4.920200E-02 |
| Stage1-vs-Stage4 |
1.709160E-01 |
| Stage2-vs-Stage3 |
2.729000E-01 |
| Stage2-vs-Stage4 |
3.201200E-01 |
| Stage3-vs-Stage4 |
6.898600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.708610E-01 |
| Normal-vs-AfricanAmerican |
5.386600E-01 |
| Normal-vs-Asian |
5.253600E-01 |
| Caucasian-vs-AfricanAmerican |
6.206400E-01 |
| Caucasian-vs-Asian |
1.646010E-01 |
| AfricanAmerican-vs-Asian |
2.479200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.976300E-03 |
| Normal-vs-Female |
1.716420E-02 |
| Male-vs-Female |
8.822799999475E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.090200E-01 |
| Normal-vs-Extreme_Weight |
4.518400E-02 |
| Normal-vs-Obese |
7.198600E-01 |
| Normal-vs-Extreme_Obese |
2.452800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.239200E-01 |
| Normal_Weight-vs-Obese |
9.596800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.560000E-01 |
| Extreme_Weight-vs-Obese |
1.620040E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.747800E-01 |
| Obese-vs-Extreme_Obese |
3.243200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.102000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.377600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.162100E-02 |
| Normal-vs-Age(81-100Yrs) |
8.314300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.701620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.130300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.473600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.281700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.178040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.169800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.017620E-02 |
| Normal-VS-Type2 PRCC |
8.560600E-01 |
| Normal-VS-KIRP CIMP |
2.346300E-02 |
| Normal-VS-Unclassified PRCC |
9.036000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.187900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.422100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.830400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.005600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.037600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.621700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.153400E-01 |
| Normal-vs-N1 |
5.245900E-02 |
| Normal-vs-N2 |
4.332400E-01 |
| N0-vs-N1 |
1.413970E-02 |
| N0-vs-N2 |
3.633800E-01 |
| N1-vs-N2 |
6.149400E-01 |
|
|
